Fluvoxamine Effective as a COVID-19 Treatment

healthline.com
April 6, 2022

Researchers in Canada conclude, based on results from 3 clinical trials, that fluvoxamine (a well-known antidepressant) used, at-home, to treat early COVID-19 is associated with reduced risk of hospitalization.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!